Expanding agricultural genomics: Solis adds Ferris bioinformatics platform

Solis Agrosciences has acquired Ferris Genomics’ sequencing and bioinformatics platform in a move aimed at expanding its capacity to deliver end-to-end genomics solutions. The acquisition is positioned as part of a broader effort to meet growing demand for advanced agricultural research tools.

The Ferris Genomics platform includes whole-genome sequencing, skim sequencing, and imputation services, as well as the development of genomics-driven breeding programs. These capabilities, utilized across plant and animal research in both row and specialty crops as well as livestock, are expected to complement Solis’ existing offerings.

Charlie Bolten, co-founder and CEO of Solis Agrosciences, described the acquisition as a strategic fit for addressing customer needs and expanding the company’s reach. Key Ferris employees have joined Solis to support the transition, and Ferris’ laboratories at the Helix Center have been integrated into Solis’ operations, enabling the company to scale its research efforts efficiently.

The integration also reflects advancements in genomic technologies. Dr. Susan Martino-Catt, COO of Solis, noted that techniques such as whole-genome skim sequencing and imputation have become more cost-effective, making them accessible for broader application in breeding programs. These tools can accelerate phenotypic improvements while preserving genetic diversity, offering opportunities for innovation in both crop and livestock development.

Founded in 2022, Solis has grown rapidly by providing specialized agricultural research services, including plant transformation, gene editing, and phenotype analysis. Its clients range from startups to multinational agricultural companies. The acquisition of Ferris Genomics aligns with Solis’ strategy to address gaps in the market by adding capabilities that support agricultural innovation.

Industry observers note that the integration of Ferris’ platform into Solis’ operations could strengthen the company’s role in driving research efficiency and outcomes. By leveraging these tools, agricultural researchers and breeders may gain access to more precise genomic data, facilitating targeted improvements in crop resilience and productivity.

Solis has received investment from a range of sources, including Hermann Companies, BioGenerator Ventures, and Saloniki Investments. According to Robert Hermann, Jr., chairman and CEO of Hermann Companies, the acquisition underscores the company’s focus on long-term growth and adapting to emerging industry needs.

This development positions Solis as part of a broader trend in agricultural technology toward integrating advanced genomics into breeding programs. While challenges remain in translating these technologies into measurable agricultural gains, the acquisition highlights the increasing importance of genomics in meeting the demands of a growing global population.